These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1035 related articles for article (PubMed ID: 17582003)

  • 1. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
    Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
    J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
    Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
    J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population.
    Kaushik S; Vajpayee M; Wig N; Seth P
    Clin Exp Immunol; 2005 Nov; 142(2):388-97. PubMed ID: 16232229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine.
    Gahery H; Daniel N; Charmeteau B; Ourth L; Jackson A; Andrieu M; Choppin J; Salmon D; Pialoux G; Guillet JG
    AIDS Res Hum Retroviruses; 2006 Jul; 22(7):684-94. PubMed ID: 16831093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
    Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.
    Boaz MJ; Waters A; Murad S; Easterbrook PJ; Vyakarnam A
    J Immunol; 2002 Dec; 169(11):6376-85. PubMed ID: 12444145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia.
    Koeppe JR; Campbell TB; Rapaport EL; Wilson CC
    J Acquir Immune Defic Syndr; 2006 Feb; 41(2):140-8. PubMed ID: 16394844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
    Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
    J Virol; 2001 Dec; 75(24):11983-91. PubMed ID: 11711588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor HIV control in HLA-B*27 and B*57/58 noncontrollers is associated with limited number of polyfunctional Gag p24-specific CD8+ T cells.
    Techakriengkrai N; Tansiri Y; Hansasuta P
    AIDS; 2013 Jan; 27(1):17-27. PubMed ID: 23079801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
    Eshofonie A; van der Loeff MS; Whittle H; Jaye A
    Clin Exp Immunol; 2006 Dec; 146(3):471-8. PubMed ID: 17100767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2/IFN-gamma-secreting CD4+ and CD4+ /CD8+ T cells in humans after lipopeptide vaccination.
    Gahery H; Figueiredo S; Texier C; Pouvelle-Moratille S; Ourth L; Igea C; Surenaud M; Guillet JG; Maillere B
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):427-37. PubMed ID: 17411376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.
    Kaufmann DE; Bailey PM; Sidney J; Wagner B; Norris PJ; Johnston MN; Cosimi LA; Addo MM; Lichterfeld M; Altfeld M; Frahm N; Brander C; Sette A; Walker BD; Rosenberg ES
    J Virol; 2004 May; 78(9):4463-77. PubMed ID: 15078927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects.
    Boaz MJ; Waters A; Murad S; Easterbrook PJ; D'Sousa E; van Wheeley C; Vyakarnam A
    Clin Exp Immunol; 2003 Dec; 134(3):454-63. PubMed ID: 14632751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
    Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
    AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine.
    Gahéry-Ségard H; Pialoux G; Charmeteau B; Sermet S; Poncelet H; Raux M; Tartar A; Lévy JP; Gras-Masse H; Guillet JG
    J Virol; 2000 Feb; 74(4):1694-703. PubMed ID: 10644339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
    Buseyne F; Scott-Algara D; Corre B; Porrot F; Monchatre E; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
    Virology; 2006 Oct; 354(2):271-9. PubMed ID: 16904156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between HIV Type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China.
    Wang S; Zhuang Y; Zhai S; Zhao S; Kang W; Li X; Yu XG; Walker BD; Altfeld MA; Sun Y
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):780-7. PubMed ID: 16910834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.